Suraksha Clinic and Diagnostic IPO Details
The Suraksha Clinic and Diagnostic IPO is a book build issue with a total issue size of ₹846.25 cr, and a offer for sale of 19189330 equity shares. Suraksha Clinic and Diagnostic IPO opened for subscription on Nov 29, 2024 and closed on Dec 03, 2024. Suraksha Clinic and Diagnostic IPO is set price band at ₹420 to ₹441 per share, with a lot size of 34 shares. Minimum investment for Retail investors was ₹14,994.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Dec 04, 2024, and listed on both the NSE and BSE on Dec 06, 2024.
Kfin Technologies Limited has been appointed as the registrar. ICICI Securities Limited, Nuvama Wealth Management Limited and SBI Capital Markets Limited are the Book Running Lead Manager for the issue.
Before investing in the Suraksha Clinic and Diagnostic IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 420 – 441
- Lot Size
- 34
- Issue Size
- ₹846.25 Cr
- Minimum Investment
- ₹14994 (34 Shares)
- Listing Date
- 06 December 2024
Current GMP
₹13 (+2.95%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Suraksha Diagnostic Limited
Suraksha Diagnostic Limited is a leading provider of integrated diagnostic services, offering a comprehensive range of pathology, radiology, and medical consultation services across East and North-East India, with a network covering West Bengal, Bihar, Assam, and Meghalaya. As of June 30, 2024, Suraksha operates a central reference laboratory, 8 satellite laboratories, 49 diagnostic centers, and 166 sample collection centers. It provides over 2,300 diagnostic tests, including advanced pathology and radiology tests such as CT and MRI scans.
The company follows a "hub-and-spoke" model, where its 13 hub centers perform a full range of tests, while smaller spoke centers focus on basic services. Suraksha also integrates polyclinics within its diagnostic centers, hosting 750+ specialized doctors, offering both online and offline medical consultations.
In Fiscal 2024, Suraksha derived 95% of its revenue from its core geography of Kolkata and West Bengal, with 93.83% of revenue coming from B2C services, including individual patients using diagnostic tests, home collections, and medical consultations. The company is accredited by key bodies such as the College of American Pathologists, NABL, and NABH, ensuring high standards in its operations.
Suraksha’s strong market presence, particularly in Kolkata and surrounding regions, and its reputation for quality and convenient services have earned it industry recognition, including awards for excellence in diagnostics and customer service. The company’s strategic growth is supported by its vast network, which facilitates access to diagnostic services in remote areas, and its ability to cross-sell services through integrated health offerings.
Suraksha Clinic and Diagnostic IPO Promoters
- Dr. Somnath Chatterjee
- Ritu Mittal
- Satish Kumar Verma
Promoters Holding
Holding Pre Issue
61.07%
Holding Post Issue
48.78%
Suraksha Clinic and Diagnostic IPO Objective
The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.
Address / Contact Info
Suraksha Diagnostic Limited
Plot No. DG-12/1, Action Area 1D,
Premises No. 02-0327, New Town,
Rajarhat, Kolkata 700 156 West Bengal
Phone: 91 33 66059750
Email: investors@surakshanet.com
Website: https://www.surakshanet.com
IPO Snapshot
Book Running Lead Managers
- ICICI Securities Limited
- Nuvama Wealth Management Limited
- SBI Capital Markets Limited
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Suraksha Clinic and Diagnostic IPO is a Book-building IPO with a total issue size of ₹846.25 crore. The Suraksha Clinic and Diagnostic IPO price band is ₹420 to 441 per share. The Suraksha Clinic and Diagnostic IPO subscription opens on Fri, Nov 29, 2024, and closes on Tue, Dec 3, 2024. The Suraksha Clinic and Diagnostic IPO will be listed on the BSE,NSE. Kfin Technologies Limited is the registrar for the Suraksha Clinic and Diagnostic IPO.
The Suraksha Clinic and Diagnostic IPO opens on Fri, Nov 29, 2024 and closes on Tue, Dec 3, 2024
Suraksha Clinic and Diagnostic IPO Price Band is ₹420 to 441 per share.
Suraksha Clinic and Diagnostic IPO lot size is 34 shares, Retail investors need a minimum investment of ₹14994 based on the upper price band
The minimum investment for Suraksha Clinic and Diagnostic IPO is ₹14994, based on one lot of 34 shares at the upper price band of ₹441 per share.
Investors can apply for the Suraksha Clinic and Diagnostic IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Tue, Dec 3, 2024. The application amount remains blocked until the Suraksha Clinic and Diagnostic IPO allotment is finalized.
Suraksha Clinic and Diagnostic IPO issue size is ₹846.25 crores.
Suraksha Clinic and Diagnostic IPO allotment date is Wed, Jul 1, 2026.
The registrar for Suraksha Clinic and Diagnostic IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited website to check Suraksha Clinic and Diagnostic IPO allotment status, refund processing, and other IPO-related information.
The Suraksha Clinic and Diagnostic IPO GMP (Grey Market Premium) is ₹13 as of Fri, Dec 6, 2024. Based on the upper price band of ₹441 per share, the estimated Suraksha Clinic and Diagnostic IPO listing price is ₹454, indicating a potential listing gain of approximately 0% over the issue price.